Insulin and IGFs in renal cancer risk and progression

Insulin and IGFs play a significant role in cancer development and progression, including renal cell carcinoma (RCC). RCC is the most frequent type of kidney cancer in adults and the tenth most common malignancy worldwide. Insulin is normally associated with metabolism control, whereas IGFs are defined as proliferation regulators. Today, there is convincing evidence of an association between obesity and the risk of RCC. Indicated risk factors together with type 2 diabetes are irreversibly connected with circulating insulin and IGF levels. The interplay between these molecules, their receptors, and IGF-binding proteins might be crucial for RCC cell biology and RCC progression. Given the potent activity IGF/IGF receptor 1 (IGF1R) inhibitors demonstrate against RCC in basic research, some type of combination therapy may prove to be beneficial clinically in the management of RCC. This review addresses not only molecular but also clinical associations between insulin and IGF1 signaling pathways and both RCC biology and clinical course. Revealing these interactions may improve our understanding of basic molecular oncology processes in RCC and improve treatment strategies.

Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells

In recent years, cancer stem cells (CSCs)/tumor initiating cells (TICs) have been identified inside different tumors. However, currently used anti-cancer therapies are mostly directed against somatic tumor cells without targeting CSCs/TICs. CSCs/TICs also gain resistance to chemotherapies/radiotherapies. For the development of efficient treatment strategies, choosing the best method for isolation and characterization of CSCs/TICs is still debated among the scientific community. In this review, we summarize recent data concerning isolation techniques for CSCs using magnetic cell sorting and flow cytometry. The review focuses on the strategies for sample preparation during flow cytometric analysis, elaborating biomarkers such as CXCR4, CD105, and CD133. In addition, functional properties characteristic of CSCs/TICs using side population selection through Hoechst 33342 dye, aldehyde dehydrogenase 1, dye-cycle violet, and rhodamine 123 are also discussed. We also include a special focus on enriching CSCs/TICs using three-dimensional cell culture models such as agarose–agarose microbeads and sphere formation.

Effect of humic acid (HA) on sulfonamide sorption by biochars

Effect of quantity and fractionation of loaded humic acid (HA) on biochar sorption for sulfonamides was investigated. The HA was applied in two different modes, i.e. pre-coating and co-introduction with sorbate. In pre-coating mode, the polar fractions of HA tended to interact with low-temperature biochars via H-bonding, while the hydrophobic fractions were likely to be adsorbed by high-temperature biochars through hydrophobic and π-π interactions, leading to different composition and structure of the HA adlayers. The influences of HA fractionation on biochar sorption for sulfonamides varied significantly, depending on the nature of interaction between HA fraction and sorbate. Meanwhile, co-introduction of HA with sulfonamides revealed that the effect of HA on sulfonamide sorption was also dependent on HA concentration. These findings suggest that the amount and fractionation of adsorbed HA are tailored by the surface properties of underlying biochars, which differently affect the sorption for organic contaminants.

Interleukin-6 as an emerging regulator of renal cell cancer

BACKGROUND

Our knowledge on the molecular basis of kidney cancer metastasisis still relatively low. About 25-30% of patients suffering from clear cell renal cell carcinoma (ccRCC)present metastatic disease at the time of primary diagnosis. Only 10% of patients diagnosed with stage IV disease survive 5 years and 20-50% of patients diagnosed with localized tumor develop metastases within 3 years. High mortality of patients with this cancer is associated with a large potential for metastasis and resistance to oncologic treatments such as chemo- and radiotherapy. Literature data based on studies conducted on other types of cancers suggest that in metastatic ccRCC, the complex of interleukin-6 (IL-6) and its soluble receptor (sIL-6R; complex IL-6/sIL-6R) and the signal transduction pathway (gp130/STAT3) might play a key role in this process.

PURPOSE

Therefore, in this review we focus on the role of IL-6 and its signaling pathways as a factor for development and spread of RCC. Analyzing the molecular basis of cancer spreading will enable the development of prognostic tests, evaluate individual predisposition for metastasis, and produce drugs that target metastases. As the development of effective systemic treatments evolve from advancements in molecular biology, continued studies directed at understanding the genetic and molecular complexities of this disease are critical to improve RCC treatment options.

The role of prostaglandin E2 in renal cell cancer development: future implications for prognosis and therapy

COX-2 plays a crucial pathophysiological role in the development of renal cell cancer (RCC). Recently, it has been shown that COX-2 inhibition enhances the efficacy of immunotherapy and tyrosine kinase inhibitor-based treatment. At the same time, molecular analyses revealed particular contribution of a COX-2 product - prostaglandin E2 (PGE2) - in RCC development. PGE2 was shown to activate Akt/RGC2/RalA signaling cascade in RCC cells. It also demonstrated upregulation of the expression of HIF-1α and PI3K/Akt/mTOR signaling pathway. All together, these data suggest that targeted anti-PGE2 therapies may offer an interesting therapeutic option for RCC patients in the future.

Future perspectives for mTOR inhibitors in renal cell cancer treatment

ABSTRACT 

Everolimus is a mTOR inhibitor that demonstrates antitumor and antiangiogenic activities. In a randomized Phase III trial, patients with metastatic renal cell carcinoma who progressed on sunitinib/sorafenib were treated with everolimus and showed significant improvement in progression-free survival compared with best supportive care. Novel approaches in treatment are expected to ensure less toxic therapies and increase efficacy of everolimus. To provide a new perspective for mTOR inhibitor research and therapy, we discuss renal cell carcinoma cancer stem cells as a potential target for mTOR inhibitors and present new concepts on emerging antiangiogenic therapies. Finally, we point why systems biology approach with reverse molecular engineering may also contribute to the field of drug discovery in renal cell carcinoma.

The role of the cell-cell interactions in cancer progression

In the field of cancer research, scientific investigations are based on analysing differences in the secretome, the proteome, the transcriptome, the expression of cell surface molecules, and the deregulation of signal transduction pathways between neoplastic and normal cells. Accumulating evidence indicates a crucial role in carcinogenesis concerning not only stromal cells but also normal cells from target organs and tissue where tumours emerge. The tumour microenvironment (TME) definitively plays an important role in regulating neighbouring cell behaviour. To date, limited attention has been focused upon interactions between cancer cells and normal cells. This review concentrates on the interactions between stromal and healthy cells from the TME in cancer development. In the article, the authors also describe mutations, genes and proteins expression pattern that are involved in tumour development in target organ.

Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma

Mammalian target of rapamycin (mTOR) is a kinase protein involved in PI3K/AKT signaling with a central role in the processes of cell growth, survival and angiogenesis. Frequent mutations of this pathway make upstream and downstream components novel targets for tailored therapy design. Two mTOR inhibitors - everolimus and temsirolimus - enable an increase in overall survival (OS) or progression-free survival (PFS) time in a treatment of renal cancer. Despite recent advances in renal cancer treatment, resistance to targeted therapy is common. Understanding of molecular mechanisms is the basis of drug resistance which can facilitate prediction of success or failure in combinational or sequential targeted therapy. The article provides current knowledge on the mTOR signaling network and gives insight into the mechanisms of resistance to mTOR inhibitors from the complex perspective of RCC biology. The mechanisms of resistance developed not only by cancer cells, but also by interactions with tumor microenvironment are analyzed to emphasize the role of angiogenesis in ccRCC pathogenesis. As recent studies have shown the role of PI3K/AKT-mTOR pathway in proliferation and differentiation of cancer stem cells, we discuss cancer stem cell hypothesis and its possible contribution to ccRCC resistance. In the context of drug resistance, we also elaborate on a new approach considering ccRCC as a metabolic disease. In conclusion we speculate on future developments in agents targeting the mTOR pathway taking into consideration the singular biology of ccRCC.

Clinical and molecular prognostic and predictive biomarkers in clear cell renal cell cancer

ABSTRACT 

The natural history of clear cell renal cell cancer is highly unpredictable with various progressors and with populations where small renal masses may be accompanied by metastatic disease. Currently, there is a critical need to determine patient risk and optimize treatment regimes. For these patients, molecular markers may offer significant information in terms of prognostic and predictive values, as well as determination of valid therapeutic targets. Until now, only a few of the many identified clear cell renal cell cancer biomarkers have been clinically validated in large cohorts. And only several biomarkers are integrated in predictive or prognostic models. Therefore, a large cohesive effort is required to advance the field of clear cell renal cell cancer prognostic biomarkers through systematic discovery, verification, validation and clinical implementation.

Renal cell carcinoma with intramyocardial metastases

Background

Cardiac metastases from renal cell carcinoma without vena caval involvement are extremely rare with a limited number of cases reported in the worldwide literature until now. Nevertheless, this rare location of metastasis may significantly influence patient treatment and prognosis. Cooperation between oncology, cardiology, and urology teams are indispensable in cases of patients suffering from intramyocardial tumors. For these individuals, treatment guidelines based on large-scale studies are unavailable and only case/case series analysis may provide clinicians with decision assistance.

Case presentation

In this paper, we report a case of a 50-year-old Caucasian male diagnosed with a 10.2 × 10.3 × 10.0 cm lower pole left renal mass in January 2002. He was subsequently treated with immunochemotherapy, tyrosine kinase inhibitors (TKIs), and mTOR inhibitors (mTORIs) - that is sunitinib, everolimus, and sorafenib. In March 2012, contrast-enhancing tumors in the left myocardium (∅22 mm) and in the interventricular septum (∅26 mm) were seen on CT. Cardiology testing was conducted and the patient was treated with pazopanib with a profound response. Overall survival since the clear cell renal cell carcinoma (ccRCC) diagnosis was 11 years 2 months and since diagnosis of multiple heart metastases was 1 year.

Conclusions

Cardiac metastases present a unique disease course in renal cell carcinoma. Cardiac metastases may remain asymptomatic, as in the case of this patient at the time of diagnosis. The most common cardiac presentation of renal cell carcinoma is hypertension, but other cardiac presentations include shortness of breath, cough, and arrhythmias. Targeted systemic therapy with tyrosine kinase inhibitors may be useful for this group of patients, but necrosis in the myocardium can result in tamponade and death. Regular cardiac magnetic resonance imaging scans are required for treatment monitoring.

Biochars derived from various crop straws: characterization and Cd(II) removal potential

Five types of biochars prepared from four crop straws and one wood shaving at 600 °C were characterized, and their sorption to Cd(II) were determined to investigate the differences in capacity to function as sorbents to heavy metals. Surface areas and pore volumes of the biochars were inversely correlated to the lignin content of raw biomass. The biochars derived from crop straws displayed more developed pore structure than wood char due to the higher lignin content of wood. Sorption capacity of the biochars to Cd(II) followed the order of corn straw>cotton straw>wheat straw>rice straw>poplar shaving, which was not strictly consistent with the surface area of the chars. The surface characteristics of chars before and after Cd(II) sorption were investigated with scanning electron microscopy equipped with an energy dispersive X-ray spectroscopy and Fourier transform infrared spectroscopy, which suggested that the higher sorption of Cd(II) on corn straw chars was mainly attributed to cation exchange, surface precipitation of carbonate, and surface complexation with oxygen-containing groups. This study indicated that crop straw biochars exhibit distinct sorption capacities to heavy metals due to various surface characteristics, and thus the sorption efficiency should be carefully evaluated specific to target contaminant.

Field evaluation of in situ remediation of Cd-contaminated soil using four additives, two foliar fertilisers and two varieties of pakchoi

This study was conducted to determine the optimal planting mode for pakchoi (Brassica rapa chinensis) in Cd-contaminated soil to reduce the accumulation of Cd in the edible parts while maintaining yields. Four additives (red mud (RM), silicon calcium fertiliser (SC), spodium (SP) and calcium magnesium phosphate (CMP)), two foliar fertilisers (Ca and Zn) and two varieties of pakchoi (Aijiaohuang (AJ) and Baixuegongzhu (BX)) were used in this study. The results show that the addition of SC and RM had an effect, but the other additives did not appear to increase the biomasses of AJ and BX. In some cases, the growth responses of AJ and BX to the same treatment were different. Extra additions of Ca or Zn to additive-treated pakchoi did not help the additives stimulate the growth of AJ and BX, except for SC-treated AJ and BX and SP-treated AJ. The SC and CMP additives significantly reduced the available Cd concentration in both the AJ soil and the BX soil; however, they did not significantly decrease the Cd concentration in the aboveground parts of AJ and BX. The RM treatments (for both levels) and some treatments containing SP reduced the available Cd concentration in the soils and reduced the accumulation of Cd in the two pakchoi varieties. Additions of Ca or Zn fertiliser significantly reduced the Cd concentration in the aboveground parts of AJ and BX. However, when Ca or Zn was sprayed on the additive-treated AJ and BX, they did not help the additives reduce the Cd accumulation in the aboveground parts of AJ and BX, except for the additive CMP. This study shows that RM may be an optimal amendment to reduce the accumulation of Cd in the edible part of pakchoi while simultaneously maintaining yields. The utilisation of Ca or Zn as a foliar fertiliser to additive-treated pakchoi showed positive effects only under some conditions.

Mechanistic understanding of tetracycline sorption on waste tire powder and its chars as affected by Cu(2+) and pH

The sorption characteristics of tetracycline (TC) by waste tire powder and its chars were investigated to explore the potential of using waste tires as effective sorbents for removal of TC from aqueous solution. Naphthalene (NAPH), a typical hydrophobic organic compound, was selected as asorbate for comparison. TC displayed much lower sorption affinity to tire powder than NAPH. However, it exhibited similar adsorption affinity as NAPH on the pyrolyzed tire chars, which was mainly attributed to π-π electron-donor-acceptor interactions of TC with the graphite surface of chars. TC and Cu(2+) could mutually facilitate the sorption of each other on both tire powder and pyrolyzed chars in a wide pH range. This could be explained by the metallic complexation and/or surface-bridging mechanisms (i.e., Cu- or TC-bridging). However, Cu(2+) and NAPH depressed the sorption of each other on tire powder and displayed negligible impact to each other on the highly pyrolyzed chars.

Adsorptive removal of hydrophobic organic compounds by carbonaceous adsorbents: a comparative study of waste-polymer-based, coal-based activated carbon, and carbon nanotubes

Adsorption of the hydrophobic organic compounds (HOCs) trichloroethylene (TCE), 1,3-dichlorobenzene (DCB), 1,3-dinitrobenzene (DNB) and gamma-hexachlorocyclohexane (HCH) on five different carbonaceous materials was compared. The adsorbents included three polymer-based activated carbons, one coal-based activated carbon (F400) and multiwalled carbon nanotubes (MWNT). The polymer-based activated carbons were prepared using KOH activation from waste polymers: polyvinyl chloride (PVC), polyethyleneterephthalate (PET) and tire rubber (TR). Compared with F400 and MWNT, activated carbons derived from PVC and PET exhibited fast adsorption kinetics and high adsorption capacity toward the HOCs, attributed to their extremely large hydrophobic surface area (2700 m2/g) and highly mesoporous structures. Adsorption of small-sized TCE was stronger on the tire-rubber-based carbon and F400 resulting from the pore-filling effect. In contrast, due to the molecular sieving effect, their adsorption on HCH was lower. MWNT exhibited the lowest adsorption capacity toward HOCs because of its low surface area and characteristic of aggregating in aqueous solution.

[Adsorption and desorption of dyes by waste-polymer-derived activated carbons]

Mesoporous activated carbons with high surface area were prepared from three waste polymers, i. e., tire rubber, polyvinyl chloride (PVC) and polyethyleneterephtalate (PET), by KOH activation. The adsorption/desorption characteristics of dyes (methylene blue and methyl orange) on the carbons were studied. The effects of pH, ionic strength and surface surfactants in the solution on the dye adsorption were also investigated. The results indicated that the carbons derived from PVC and PET exhibited high surface area of 2 666 and 2 831 m2 x g(-1). Their mesopore volume were as high as 1.06 and 1.30 cm3 g(-1), respectively. 98.5% and 97.0% of methylene blue and methyl orange were removed in 15 min by PVC carbon, and that of 99.5% and 95.0% for PET carbon. The Langmuir maximum adsorption capacity to these dyes was more than 2 mmol x g(-1), much higher than that of commercial activated carbon F400. Compared with Freundlich model, the adsorption data was fitted better by Langmiur model, indicating monolayer coverage on the carbons. The adsorption was highly dependent on solution pH, ionic strength and concentration of surface surfactants. The activated carbons exhibited higher adsorption to methylene blue than that of methyl orange, and it was very hard for both of the dyes to be desorbed. The observation in this study demonstrated that activated carbons derived from polymer waste could be effective adsorbents for the treatment of wastewater with dyes.